News

BioCryst Pharmaceuticals Plans Fourth Quarter Financial Call

BioCryst Pharmaceuticals Plans Fourth Quarter Financial Call

BioCryst Pharmaceuticals to Discuss Upcoming Financial Results

BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) has announced its schedule to report financial results for the fourth quarter of 2024. This important update is set for a Monday in late February.

Insights from the Conference Call

The company’s management will host a conference call on the same day at 8:30 a.m. ET. During this event, they will review the fourth quarter's financial outcomes and provide insights into the company's strategic direction and developments. This is an excellent opportunity for investors and stakeholders to gain meaningful information directly from the company’s leadership.

Accessing the Call

To participate in the live call, domestic callers can dial 1-844-481-2942, while international participants should use the number 1-412-317-1866. For those unable to attend, a live webcast and a replay of the call will be accessible through the investor section of the BioCryst Pharmaceuticals website.

About BioCryst Pharmaceuticals

Founded with a mission to change the lives of individuals with complement-mediated and other rare diseases, BioCryst Pharmaceuticals stands at the forefront of biotechnology. The company utilizes its proficiency in structure-guided drug design to develop innovative therapies that are often groundbreaking for challenging medical conditions.

One of BioCryst’s notable achievements is the commercialization of ORLADEYO, a pioneering oral medication that functions as a plasma kallikrein inhibitor, administered once daily. This reflects the company’s dedication to delivering first-in-class solutions to patients.

Pipeline of Innovations

Beyond ORLADEYO, BioCryst boasts a broad pipeline of promising small-molecule and protein therapeutics aimed at addressing various challenges in disease treatment. Their ongoing commitment to research and development is central to their strategy of expanding treatment options for patients worldwide.

Connect with BioCryst Pharmaceuticals

For continuous updates and detailed information about BioCryst’s advancements, investors are encouraged to explore the official BioCryst Pharmaceuticals website or follow their social media channels.

Contact Information

For inquiries, please reach out to John Bluth at +1 919 859 7910 or contact via email at jbluth@biocryst.com.

Frequently Asked Questions

When will BioCryst report its financial results?

BioCryst is set to report its fourth quarter 2024 financial results on a Monday in late February.

What time is the conference call scheduled?

The conference call is scheduled for 8:30 a.m. ET on the same day as the financial results announcement.

How can I access the conference call?

Domestic callers can dial 1-844-481-2942, and international callers can dial 1-412-317-1866 to join the call.

Where can I find the webcast of the call?

A live webcast and replay of the conference call will be available on BioCryst's investor section of their website.

What role does BioCryst Pharmaceuticals play in biotechnology?

BioCryst is dedicated to improving the lives of individuals with rare diseases through innovative drug development and advanced research.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 6

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 1

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 6

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 2

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 4

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 3

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 3

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 4

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading

Top 5 Most Recently Viewed Articles

ANEW Medical Expands Portfolio with Needle-Free Technology

Updated Category News Views 79

ANEW Medical, Inc. Acquires Innovative Technology ANEW MEDICAL, INC. (“ANEW” or the “Company”) (Nasdaq: WENA) has announced that it has signed an exclusive worldwide licensing agreement with Transfertech Sherbrooke (“TTS”) for Nanoject. This innovative technology is a needle-free, freeze-dried nanopowder autoinjector designed for administering medicines and...

Continue Reading
Empire Media Worx Partners with Ultrack for Better Pets Brand Growth

Updated Category News Views 145

Ultrack Systems Inc. Engages Empire Media Worx for Better Pets Ultrack Systems Inc. (OTC: MJLB) is excited to announce a strategic partnership with Empire Media Worx Inc., aiming to revamp its Better Pets division. This creative collaboration marks a significant step for Ultrack, a technology firm actively involved in the pet wellness market. A Landmark Collaboration for...

Continue Reading
Key Highlights from the Recent Annual General Meeting

Updated Category News Views 338

Key Highlights from the Recent Annual General Meeting In a significant event for shareholders and stakeholders alike, the annual general meeting of Ringkjøbing Landbobank was held, where important decisions regarding the bank’s operations were discussed and voted upon. Many notable aspects were covered during this assembly, which marks a key moment in the bank's fiscal...

Continue Reading
AMD Forms Strategic Alliance with Absci for Healthcare AI Growth

Updated Category News Views 221

AMD Strengthens Its Position in AI Through Absci Investment Advanced Micro Devices (NASDAQ: AMD) has decided to invest $20 million in Absci, a drug-discovery company. This investment marks AMD's entry into the healthcare sector, focusing on the utilization of its advanced artificial intelligence (AI) chips. The aim is to enhance the capabilities of AI in the healthcare...

Continue Reading
Legacy Commercial Property's Strategic Retail Expansion in Alabama

Updated Category News Views 164

Legacy Commercial Property Expands Its Horizons Legacy Commercial Property has made an important move in the retail sector by acquiring the Hunnington Center, a significant retail plaza that spans 55,000 square feet. This new property is situated on Memorial Parkway, right in the heart of a rapidly growing area. It’s an exciting time for the company as they broaden...

Continue Reading